Cargando…
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052914/ https://www.ncbi.nlm.nih.gov/pubmed/35112554 http://dx.doi.org/10.3324/haematol.2021.279999 |
_version_ | 1784696884393148416 |
---|---|
author | Mei, Matthew Hamadani, Mehdi Ahn, Kwang W. Chen, Yue Kharfan-Dabaja, Mohamed A. Sauter, Craig Herrera, Alex F. |
author_facet | Mei, Matthew Hamadani, Mehdi Ahn, Kwang W. Chen, Yue Kharfan-Dabaja, Mohamed A. Sauter, Craig Herrera, Alex F. |
author_sort | Mei, Matthew |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9052914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-90529142022-05-13 Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit Mei, Matthew Hamadani, Mehdi Ahn, Kwang W. Chen, Yue Kharfan-Dabaja, Mohamed A. Sauter, Craig Herrera, Alex F. Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-02-03 /pmc/articles/PMC9052914/ /pubmed/35112554 http://dx.doi.org/10.3324/haematol.2021.279999 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letters to the Editor Mei, Matthew Hamadani, Mehdi Ahn, Kwang W. Chen, Yue Kharfan-Dabaja, Mohamed A. Sauter, Craig Herrera, Alex F. Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
title | Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
title_full | Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
title_fullStr | Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
title_full_unstemmed | Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
title_short | Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
title_sort | autologous hematopoietic cell transplantation in diffuse large b-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052914/ https://www.ncbi.nlm.nih.gov/pubmed/35112554 http://dx.doi.org/10.3324/haematol.2021.279999 |
work_keys_str_mv | AT meimatthew autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit AT hamadanimehdi autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit AT ahnkwangw autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit AT chenyue autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit AT kharfandabajamohameda autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit AT sautercraig autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit AT herreraalexf autologoushematopoieticcelltransplantationindiffuselargebcelllymphomaafterthreeormorelinesofpriortherapyevidenceofdurablebenefit |